1 Match for Cherif Benattia from Ardmore, Pennsylvania, USA

Cherif Benattia Age 39

Villanova, PA | Ardmore, PA | Haverford, PA

Cherif Benattia, MD brings 25 years of experience in the pharmaceutical industry with solid expertise in Drug Safety (PV), Risk Management, Crisis Mgt, Risk and Crisis Communication. He joined Vertex Pharmaceuticals in 2007, as VP, PV & Public Health with a mission to develop a new model for Drug Safety. His vision is a necessary shift from “Drug Safety” to ‘Patient Safety”. Fully supported by J. Boger, Vertex former CEO, they changed the name of the Safety Dpt to “Patient Safety, PV & Public Health” to reflect this vision and the dedication to patients. Dr Benattia worked also closely with FDA, Bio and MIT CBI on numerous projects like the “Sentinel Initiative” and the “Framework for Risk Benefit Mgt”. He left Vertex in June 09 and is back to consulting and teaching. He wants to dedicate his time to a new initiative “Patient Safety First”, not only to protect patients but also to prevent harm, through education and a better Benefit Risk Communication. Before joining Vertex, he was the Founder of APhaRC, LLC, a research and consulting company with a specialty practice in Risk Mgt (RiskMAPs and REMS), Crisis Management, Crisis and Risk Communication, Pharmacovigilance and Inspection preparedness. Before founding APhaRC, Dr. Benattia was the VP of Global PV Education and OC Support for J&J after being the VP of Drug Safety Operations and Information Mgt. Prior to J&J, Dr. Benattia spent 7 years at Pfizer mainly at the NY HQ where he held a variety of senior positions including Dir of Medical & Reg Affairs. He also served as Therapeutic Area Dir in the WW Safety Division. Dr Benattia has also a broad experience in humanitarian and philanthropic activities and has worked in Kenya with the Flying Doctors of Africa. He has supported and sponsored clinical research programs including AIDS and the Trachoma initiative. He is a frequent guest speaker throughout the world and teaches at Paris VI University and at the ESSEC business school on Risk Mgt and Crisis Management. Specialties Risk Communication Risk Benefit Management, RiskMAPs, REMS Drug Safety/ Pharmacovigilance Crisis Management and Crisis Communication FDA inspections Audits Clinical Development & Clinical Trials Regulatory Affairs, Philanthropic/Public Affairs. Medical Education & Training